{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:29:43Z","timestamp":1778894983602,"version":"3.51.4"},"reference-count":18,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2009,4,14]],"date-time":"2009-04-14T00:00:00Z","timestamp":1239667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold>Administration of imipenem\u2010cilastatin to patients with IgE\u2010mediated hypersensitivity to \u03b2\u2010lactams has always been considered potentially harmful. Recent studies have demonstrated the tolerability of carbapenems (imipenem\u2010cilastatin and meropenem) in patients with IgE\u2010mediated hypersensitivity to \u03b2\u2010lactams; there are no studies on this topic regarding patients with cell\u2010mediated allergy to \u03b2\u2010lactams. The aim of this study is to assess cross\u2010reactivity and tolerability of imipenem in patients with cell\u2010mediated allergy to \u03b2\u2010lactams.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>From our database we selected 73 patients with cell\u2010mediated allergy to \u03b2\u2010lactams, diagnosed by means of immediate\u2010type skin tests, delayed reading intradermal tests, patch tests and detection of specific IgE. Patients with negative patch tests with imipenem\u2010cilastatin underwent an intramuscular test dosing.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Our patients had a total of 94 nonimmediate reactions to penicillins. All patients had positive patch tests and\/or delayed reading intradermal tests for at least one of the penicillin reagent tested and negative immediate\u2010type skin tests and specific IgE. Four patients out of 73 had a positive patch tests to at least one penicillin reagent and imipenem\u2010cilastatin showing cross\u2010reactivity. Sixty\u2010four patients underwent the imipenem\u2010cilastatin intramuscular test dosing and none of them had a clinical reaction.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>Our rate of cross\u2010reactivity between imipenem\u2010cilastatin and other \u03b2\u2010lactams was 5.5%. This result is different from previous findings and this may be explained by the fact that we investigated patients with cell\u2010mediated allergy to \u03b2\u2010lactams. Patients with cell\u2010mediated allergy to \u03b2\u2010lactams should undergo patch tests and a tolerance challenge test before treatment with imipenem\u2010cilastatin.<\/jats:p>","DOI":"10.1111\/j.1398-9995.2009.02058.x","type":"journal-article","created":{"date-parts":[[2009,4,14]],"date-time":"2009-04-14T08:09:03Z","timestamp":1239696543000},"page":"1644-1648","source":"Crossref","is-referenced-by-count":24,"title":["Cross\u2010reactivity and tolerability of imipenem in patients with delayed\u2010type, cell\u2010mediated hypersensitivity to \u03b2\u2010lactams"],"prefix":"10.1111","volume":"64","author":[{"given":"D.","family":"Schiavino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Nucera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Decinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pascolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Altomonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Buonomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Patriarca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,8]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)91001-9"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199410040-00006"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/317507"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh454"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/382880"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc053529"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-4-200702200-00005"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01532.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.39.765"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000024088"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00280.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01272.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow K","year":"2002","journal-title":"Allergy"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00678.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/039463200601900412"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2498"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1398-9995.2003.00308.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62650-6"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2009.02058.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.2009.02058.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T15:55:56Z","timestamp":1710258956000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2009.02058.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,8]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1398-9995.2009.02058.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2009.02058.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,8]]}}}